<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>1267</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>14671105</PubmedId>
            <Abstract>We used a panel of monoclonal antibodies to H9 hemagglutinin to select 18 escape mutants of mouse-adapted influenza A/Swine/Hong Kong/9/98 (H9N2) virus. Cross-reactions of the mutants with the antibodies and the sequencing of hemagglutinin genes revealed two minimally overlapping epitopes. We mapped the amino acid changes to two areas of the recently reported three-dimensional structure of A/Swine/Hong Kong/9/98 hemagglutinin. The grouping of the antigenically relevant amino acid positions in H9 hemagglutinin differs from the pattern observed in H3 and H5 hemagglutinins. Several positions in site B of H3 hemagglutinin are distributed in two sites of H9 hemagglutinin. Unlike any subtype analyzed so far, H9 hemagglutinin does not contain an antigenic site corresponding to site A in H3 hemagglutinin. Positions 145 and 193 (H3 numbering), which in H3 hemagglutinin belong to sites A and B, respectively, are within one site in H9 hemagglutinin. This finding is consistent with the peculiarity of the three-dimensional structure of the H9 molecule, that is, the absence from H9 hemagglutinin of the lateral loop that forms site A in H3 and the equivalent site in H5 hemagglutinins. The escape mutants analyzed displayed phenotypic variations, including decreased virulence for mice and changes in affinity for sialyl substrates. Our results demonstrate a correlation between intersubtype differences in three-dimensional structure and variations among subtypes in the distribution of antigenic areas. Our findings also suggest that covariation and pleiotropic effects of antibody-selected mutations may be important in the evolution of H9 influenza virus, a possible causative agent of a future pandemic.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>240-9</ArticlePages>
            <ArticleTitle>Structural differences among hemagglutinins of influenza A virus subtypes are reflected in their antigenic architecture: analysis of H9 escape mutants.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Kaverin</LastName>
                    <ForeName>Nikolai V</ForeName>
                </Author>
                <Author>
                    <LastName>Rudneva</LastName>
                    <ForeName>Irina A</ForeName>
                </Author>
                <Author>
                    <LastName>Ilyushina</LastName>
                    <ForeName>Natalia A</ForeName>
                </Author>
                <Author>
                    <LastName>Lipatov</LastName>
                    <ForeName>Aleksandr S</ForeName>
                </Author>
                <Author>
                    <LastName>Krauss</LastName>
                    <ForeName>Scott</ForeName>
                </Author>
                <Author>
                    <LastName>Webster</LastName>
                    <ForeName>Robert G</ForeName>
                </Author>
            </Authors>
            <Affiliations>D. I. Ivanovsky Institute of Virology, 123098 Moscow, Russia.</Affiliations>
            <ArticleChemicalList>Hemagglutinin Glycoproteins, Influenza Virus;N-Acetylneuraminic Acid</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Substitution; Animals; Antigenic Variation; Genetic Variation; Hemagglutinin Glycoproteins, Influenza Virus(chemistry; genetics; immunology); Humans; Influenza A virus(classification; genetics; immunology; pathogenicity); Influenza, Human(immunology; physiopathology; virology); Mice; Models, Molecular; Molecular Sequence Data; N-Acetylneuraminic Acid(metabolism); Sequence Analysis, DNA; Swine; Virulence</ArticleMeshHeadingsList>
            <Journal>
                <Volume>78</Volume>
                <Issue>1</Issue>
                <Title>Journal of virology</Title>
                <Issn>1098-5514</Issn>
                <MedlineTa>J Virol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>I</EpitopeName>
                <EpitopeStructure>
                    <DiscontinuousRegionOnAccessionSequenceMolecule>
                        <ChemicalType>Discontinuous protein residues</ChemicalType>
                        <DiscontinuousResidues>S145, T147, K165, P170, T197, T206</DiscontinuousResidues>
                        <SourceMolecule>
                            <GenBankId>AAL14080.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>145307</SourceOrganismId>
                    </DiscontinuousRegionOnAccessionSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 4 and Table 3</LocationOfData>
                <EpitopeId>76998</EpitopeId>
                <ReferenceRegion>S127, T129, K147, P152, T179, T188</ReferenceRegion>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Partial Epitope</EpitopeStructureDefines>
                <EpitopeComments>Key residues were identified by sequencing viral escape mutants of a mouse-adapted influenza A/Swine/Hong Kong/9/98 (H9N2) virus that were selected with a panel of ten monoclonal antibodies to the hemagglutinin of three H9N2 strains. The pattern of resistance revealed the presence of two minimally overlapping epitopes, I and II, each consisting of several amino acid positions. Some antibodies interacted with parts of both antigenic areas. The amino acid position numbers for the H9 subtype of HA were taken from Table 3.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <BCellId>18683</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>8 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>145307</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus (A/swine/Hong Kong/9/98(H9N2))</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>4</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were infected intranasally at day 0. After one month, the mice were immunized by intraperitoneal injections of virus with IFA.  Two and four weeks later, mice were given booster intravenous injections.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>In addition to G9-6, other mAbs tested that recognized epitope I included 15F1, G9-27, G1-26, G1-29, G9-25 and 18G4.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>G9-6</AssayedAntibodyName>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Influenza A virus (A/swine/Hong Kong/9/98(H9N2))</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>145307</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>II</EpitopeName>
                <EpitopeStructure>
                    <DiscontinuousRegionOnAccessionSequenceMolecule>
                        <ChemicalType>Discontinuous protein residues</ChemicalType>
                        <DiscontinuousResidues>S145, D153, T197, N201, T206, L234</DiscontinuousResidues>
                        <SourceMolecule>
                            <GenBankId>AAL14080.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>145307</SourceOrganismId>
                    </DiscontinuousRegionOnAccessionSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 4 and Table 3</LocationOfData>
                <EpitopeId>76997</EpitopeId>
                <ReferenceRegion>S127, D135, T179, N183, T188, L216</ReferenceRegion>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Partial Epitope</EpitopeStructureDefines>
                <EpitopeComments>Key residues were identified by sequencing viral escape mutants of a mouse-adapted influenza A/Swine/Hong Kong/9/98 (H9N2) virus that were selected with a panel of ten monoclonal antibodies to the hemagglutinin of three H9N2 strains. The pattern of resistance revealed the presence of two minimally overlapping epitopes, I and II, each consisting of several amino acid positions. Some antibodies interacted with parts of both antigenic areas. The amino acid position numbers  for the H9 subtype of HA were taken from Table 3.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <BCellId>18694</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>8 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>145307</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Influenza A virus (A/swine/Hong Kong/9/98(H9N2))</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>4</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were infected intranasally at day 0. After one month, the mice were immunized by intraperitoneal injections of virus with IFA.  Two and four weeks later, mice were given booster intravenous injections.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>In addition to 18B1, other mAbs tested that recognized epitope II included 19A10, 2F4, 4G3, 7B10, 3D11, 8C4 and 18B10.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>18B1</AssayedAntibodyName>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Influenza A virus (A/swine/Hong Kong/9/98(H9N2))</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>145307</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

